HYPR icon

Hyperfine

0.8851 USD
-0.0449
4.83%
At close Dec 20, 4:00 PM EST
1 day
-4.83%
5 days
-10.60%
1 month
-1.66%
3 months
-15.70%
6 months
8.34%
Year to date
-21.67%
1 year
-15.70%
5 years
-90.37%
10 years
-90.37%
 

About: Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its sales from the following sources: 1) device sales which consist of sales of MRI devices and 2) service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.

Employees: 131

0
Funds holding %
of 6,809 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

28% more capital invested

Capital invested by funds: $8.7M [Q2] → $11.2M (+$2.45M) [Q3]

0.03% less ownership

Funds ownership: 17.98% [Q2] → 17.95% (-0.03%) [Q3]

7% less funds holding

Funds holding: 43 [Q2] → 40 (-3) [Q3]

20% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 5

38% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 8

Research analyst outlook

We haven’t received any recent analyst ratings for HYPR.

Financial journalist opinion

Based on 3 articles about HYPR published over the past 30 days

Neutral
Business Wire
4 days ago
Hyperfine Expands Global Market Reach with New Distribution Partnerships in European and Middle Eastern Markets
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. announces global expansion of commercial operations into Turkey, Israel and Saudi Arabia to support Swoop® system expansion plans.
Hyperfine Expands Global Market Reach with New Distribution Partnerships in European and Middle Eastern Markets
Neutral
Business Wire
2 weeks ago
Hyperfine Announces Extensive Clinical Study Coverage at RSNA 2024, Showcasing the Body of Evidence Supporting the Use of the Swoop® System Across Different Sites of Care
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine highlights data and conclusions from eleven abstracts presented at the Radiological Society of North America 2024 Annual Meeting in Chicago.
Hyperfine Announces Extensive Clinical Study Coverage at RSNA 2024, Showcasing the Body of Evidence Supporting the Use of the Swoop® System Across Different Sites of Care
Neutral
Business Wire
2 weeks ago
Hyperfine Announces Strategic Leadership Additions to Drive Growth in Key Business Verticals
GUILFORD, Conn.--(BUSINESS WIRE)--Strategic appointments position Hyperfine to drive the adoption of the Swoop® system in hospital settings and expand into the office setting.
Hyperfine Announces Strategic Leadership Additions to Drive Growth in Key Business Verticals
Neutral
Business Wire
1 month ago
Hyperfine Swoop® Portable MR Brain Imaging System Meets New Standards Recently Issued by CMS-Approved Accrediting Body
GUILFORD, Conn.--(BUSINESS WIRE)--The new MRI standards by the IAC, effective immediately, now include portable MR scanning at the point of care.
Hyperfine Swoop® Portable MR Brain Imaging System Meets New Standards Recently Issued by CMS-Approved Accrediting Body
Neutral
Business Wire
1 month ago
Hyperfine Announces Ten Abstracts at RSNA, Highlighting the Expanding Utility and Potential of Portable MR Brain Imaging in Diverse Clinical and Research Settings
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. announces ten scientific abstracts highlighting ultra-low-field imaging will be presented at the RSNA 2024 Annual Meeting.
Hyperfine Announces Ten Abstracts at RSNA, Highlighting the Expanding Utility and Potential of Portable MR Brain Imaging in Diverse Clinical and Research Settings
Neutral
Business Wire
1 month ago
Hyperfine, Inc. to Participate in Upcoming Investor Conferences
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. to present at the BTIG Digital Health Forum on November 25, 2024 and the Mizuho Healthcare Conference on December 11, 2024.
Hyperfine, Inc. to Participate in Upcoming Investor Conferences
Neutral
Seeking Alpha
1 month ago
Hyperfine, Inc. (HYPR) Q3 2024 Earnings Call Transcript
Hyperfine, Inc. (NASDAQ:HYPR ) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Company Participants Marissa Bych - Gilmartin Group Maria Sainz - President and CEO Brett Hale - Chief Administrative Officer and CFO Conference Call Participants Yuan Zhi - B. Riley Operator Good afternoon.
Hyperfine, Inc. (HYPR) Q3 2024 Earnings Call Transcript
Neutral
Zacks Investment Research
1 month ago
Hyperfine, Inc. (HYPR) Reports Q3 Loss, Tops Revenue Estimates
Hyperfine, Inc. (HYPR) came out with a quarterly loss of $0.14 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.15 per share a year ago.
Hyperfine, Inc. (HYPR) Reports Q3 Loss, Tops Revenue Estimates
Neutral
GlobeNewsWire
1 month ago
Hyperfine, Inc. Reports Third Quarter 2024 Financial Results
GUILFORD, Connecticut, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced third quarter 2024 financial results and provided a business update.
Hyperfine, Inc. Reports Third Quarter 2024 Financial Results
Neutral
Business Wire
1 month ago
Hyperfine Announces European Launch with CE Approval
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. announces CE approval of its latest generation of AI-powered Swoop® system software under the European Medical Device Regulation.
Hyperfine Announces European Launch with CE Approval
Charts implemented using Lightweight Charts™